Research Article

Activation of Delta-Opioid Receptor Protects ARPE19 Cells against Oxygen-Glucose Deprivation/Reoxygenation-Induced Necroptosis and Apoptosis by Inhibiting the Release of TNF-α

Figure 3

The effects of the DOR agonist TAN-67 and the antagonist NTI on the viability of ARPE19 cells induced by OGD24/R36. The viability of ARPE19 cells that were pretreated with the DOR agonist TAN-67 (50, 30, 10 μM) or the antagonist NTI (50, 30, 10 μM) and stimulated with or without OGD24/R36 was determined by a cell counting kit-8 assay. (+ or − indicates with or without OGD24/R36/TAN-67/NTI) The results are expressed as proportions of surviving cells compared with the controls (n = 5 per group). Data are presented as means ± SEM, and group differences were analyzed by one-way ANOVA with Dunnett’s post hoc test. ###, compared with the control group; , , , compared with the OGD24/R36 group.